| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.03 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.064 | 0.03 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.03 |